|
1
|
Fan J and Watanabe T: Atherosclerosis:
Known and unknown. Pathol Int. 72:151–160. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fuster JJ, MacLauchlan S, Zuriaga MA,
Polackal MN, Ostriker AC, Chakraborty R, Wu CL, Sano S,
Muralidharan S, Rius C, et al: Clonal hematopoiesis associated with
TET2 deficiency accelerates atherosclerosis development in mice.
Science. 355:842–847. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lv YC, Yang J, Yao F, Xie W, Tang YY,
Ouyang XP, He PP, Tan YL, Li L, Zhang M, et al: Diosgenin inhibits
atherosclerosis via suppressing the MiR-19b-induced downregulation
of ATP-binding cassette transporter A1. Atherosclerosis. 240:80–89.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ross R: Atherosclerosis-an inflammatory
disease. N Engl J Med. 340:115–126. 1999.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chen HF, Chuang HC and Tan TH: Regulation
of dual-specificity phosphatase (DUSP) ubiquitination and protein
stability. Int J Mol Sci. 20(2668)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Huang Z, Wu LM, Zhang JL, Sabri A, Wang
SJ, Qin GJ, Guo CQ, Wen HT, Du BB, Zhang DH, et al: Dual
specificity phosphatase 12 regulates hepatic lipid metabolism
through inhibition of the lipogenesis and apoptosis
signal-regulating kinase 1 pathways. Hepatology. 70:1099–1118.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li H, Yang Q, Huang Z, Liang C, Zhang DH,
Shi HT, Du JQ, Du BB and Zhang YZ: Dual-specificity phosphatase 12
attenuates oxidative stress injury and apoptosis in diabetic
cardiomyopathy via the ASK1-JNK/p38 signaling pathway. Free Radic
Biol Med. 192:13–24. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Boldorini R, Clemente N, Alchera E and
Carini R: DUSP12 acts as a novel endogenous protective signal
against hepatic ischemia-reperfusion damage by inhibiting ASK1
pathway. Clin Sci (Lond). 135:161–166. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liu XM, Du SL, Miao R, Wang LF and Zhong
JC: Targeting the forkhead box protein P1 pathway as a novel
therapeutic approach for cardiovascular diseases. Heart Fail Rev.
27:345–355. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mulla W, Hajaj B, Elyagon S, Mor M, Gillis
R, Murninkas M, Klapper-Goldstein H, Plaschkes I, Chalifa-Caspi V,
Etzion S and Etzion Y: Rapid atrial pacing promotes atrial
fibrillation substrate in unanesthetized instrumented rats. Front
Physiol. 10(1218)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gao F, Zhao Y, Zhang B, Xiao C, Sun Z, Gao
Y and Dou X: Forkhead box protein 1 transcriptionally activates
sestrin1 to alleviate oxidized low-density lipoprotein-induced
inflammation and lipid accumulation in macrophages. Bioengineered.
13:2917–2926. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fornes O, Castro-Mondragon JA, Khan A, van
der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M,
Baranašić D, et al: JASPAR 2020: update of the open-access database
of transcription factor binding profiles. Nucleic Acids Res. 48
(D1):D87–D92. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang M, Zhu Y, Zhu J, Xie Y, Wu R, Zhong
J, Qiu Z and Jiang L: circ_0086296 induced atherosclerotic lesions
via the IFIT1/STAT1 feedback loop by sponging miR-576-3p. Cell Mol
Biol Lett. 27(80)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Trpkovic A, Resanovic I, Stanimirovic J,
Radak D, Mousa SA, Cenic-Milosevic D, Jevremovic D and Isenovic ER:
Oxidized low-density lipoprotein as a biomarker of cardiovascular
diseases. Crit Rev Clin Lab Sci. 52:70–85. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kattoor AJ, Kanuri SH and Mehta JL: Role
of Ox-LDL and LOX-1 in atherogenesis. Curr Med Chem. 26:1693–1700.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang Q, Liu J, Duan H, Li R, Peng W and
Wu C: Activation of Nrf2/HO-1 signaling: An important molecular
mechanism of herbal medicine in the treatment of atherosclerosis
via the protection of vascular endothelial cells from oxidative
stress. J Adv Res. 34:43–63. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Conti P and Shaik-Dasthagirisaeb Y:
Atherosclerosis: A chronic inflammatory disease mediated by mast
cells. Cent Eur J Immunol. 40:380–386. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hui Z, Jie H and Fan GH: Expression of
DUSP12 reduces lung vascular endothelial cell damage in a murine
model of lipopolysaccharide-induced acute lung injury via the
apoptosis signal-regulating kinase 1 (ASK1)-Jun N-terminal kinase
activation (JNK) pathway. Med Sci Monit. 27(e930429)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cheng J, Ji M, Jing H and Lin H: DUSP12
ameliorates myocardial ischemia-reperfusion injury through
HSPB8-induced mitophagy. J Biochem Mol Toxicol.
37(e23310)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cho SSL, Han J, James SJ, Png CW,
Weerasooriya M, Alonso S and Zhang Y: Dual-specificity phosphatase
12 targets p38 MAP kinase to regulate macrophage response to
intracellular bacterial infection. Front Immunol.
8(1259)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang Y, Zheng Y, Wang S, Fan Y, Ye Y,
Jing Y, Liu Z, Yang S, Xiong M, Yang K, et al: Single-nucleus
transcriptomics reveals a gatekeeper role for FOXP1 in primate
cardiac aging. Protein Cell. 14:279–293. 2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhuang T, Liu J, Chen X, Zhang L, Pi J,
Sun H, Li L, Bauer R, Wang H, Yu Z, et al: Endothelial Foxp1
suppresses atherosclerosis via modulation of Nlrp3 inflammasome
activation. Circ Res. 125:590–605. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu Q, Pan J, Bao L, Xu C, Qi Y, Jiang B,
Wang D, Zhu X, Li X, Zhang H, et al: Major vault protein prevents
atherosclerotic plaque destabilization by suppressing macrophage
ASK1-JNK signaling. Arterioscler Thromb Vasc Biol. 42:580–596.
2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hang L, Peng Y, Xiang R, Li X and Li Z:
Ox-LDL causes endothelial cell injury through ASK1/NLRP3-mediated
inflammasome activation via endoplasmic reticulum stress. Drug Des
Devel Ther. 14:731–744. 2020.PubMed/NCBI View Article : Google Scholar
|
